Get started
Author

Samuel Hricko

Observed names: Hricko, Samuel, S. Hricko
OpenAlex ID: A5092128145
Reliable detection of CNS lymphoma-derived circulating tumor DNA in cerebrospinal fluid using multi-biomarker NGS profiling: insights from a real-world study
2025 · Veronika Navrkalova, Andrea Mareckova, et al. · Biomarker Research · 8
PDF
Advanced NGS analysis of cell-free tumor DNA supports clonal relation to primary high-grade B-cell lymphoma lesion and CNS relapse despite MRI negativity
2025 · Veronika Navrkalova, Andrea Mareckova, et al. · Diagnostic Pathology · 2
PDF
FLIPI24 as a prognostic model in marginal zone lymphoma: Results from an international multi-cohort analysis
2025 · Prokop Vodicka, Matthew Maurer, et al. · Blood · 1
PDF
Vitamin d and other micronutrients influence prognosis of patients with non-Hodgkin lymphoma (NHL)
2025 · Martin Hajek, Marek Trneny, et al. · Blood · 1
Optimizing risk stratification in patients aged 80+ years with large B-cell lymphoma: Comparison of prognostic indices in three pooled international cohorts
2025 · Prokop Vodicka, Yucai Wang, et al. · Blood · 1
Validation of the CNS-IPI-C Prognostic Model in Patients with Systemic DLBCL in the Real World
2024 · Michal Masar, Prokop Vodicka, et al. · Blood · 1
PDF
Risk of Central Nervous System Vs. Systemic Relapse in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: What Should We Focus on?
2023 · Magdalena Klanova, Samuel Hricko, et al. · Blood · 1
CNS lymphoma mimicking neuro-Behçet's disease
2026 · Barbora Hanžlová, Samuel Hricko, et al. · Česká radiologie
Comparable PFS in isolated parenchymal cns vs systemic relapse of DLBCL: Results from a large real-world cohort
2025 · Michal Masar, Prokop Vodicka, et al. · Blood
PDF
Impact of primary CNS prophylaxis in high CNS-IPI DLBCL: Analysis from the czech national lymphoma registry
2025 · Samuel Hricko, Magdalena Klanova, et al. · Blood
Risk of central nervous system versus systemic relapse in patients with diffuse large B‐cell lymphoma treated with R‐CHOP: What should we focus on?
2025 · Magdalena Klanova, Samuel Hricko, et al. · HemaSphere
PDF
Primary Extranodal Follicular Lymphoma: A Retrospective Survey of the International Extranodal Lymphoma Study Group (IELSG)
2025 · Annarita Conconi, Andrea Janikova, et al. · Hematological Oncology
PDF
590 | Real World Outcomes of the First‐line Treatment of Localized Extranodal Marginal Zone Lymphoma of Ocular Adnexa or Orbit
2025 · J. Ďuraš, P. Vodička, et al. · Hematological Oncology
PDF
Author response for "Primary Extranodal Follicular Lymphoma: A Retrospective Survey of the International Extranodal Lymphoma Study Group (IELSG)"
2025 · Conconi, Annarita, Janikova, Andrea, et al.
Disseminated angiosarcoma imitating multiple myeloma
2025 · Klára Plšková, Tomáš Jůza, et al. · Česká radiologie
PDF
Do the Control Cohorts of Phase III Randomized Trials Reflect the Real-World Results of DLBCL Patients?
2023 · Prokop Vodicka, Andrea Janikova, et al. · Blood
Circulating free DNA and its potential in the diagnostics and therapy of malignant lymphoma
2023 · Samuel Hricko, Veronika Navrkalová, et al. · Klinicka onkologie
PDF
Genomic Aberrations Detected in Circulating Tumor Dna From Cerebrospinal Fluid and Plasma of Patients With Primary and Secondary Cns Lymphomas With Negative Flowcytometry
2023 · A. Mareckova, V. Navrkalova, et al. · Hematological Oncology
PDF
Works count: 23
Citation count: 15
H-index: 2
I10-index:
Year
Topic
Type